Summary & Overview
CPT 0583U: Rapid Genome Sequencing Family Member Comparator
CPT code 0583U designates a Proprietary Laboratory Analyses (PLA) test — the Rapid Genome Sequencing Family Member Comparator from Mayo Clinic — which performs rapid whole genome sequencing of a family member to compare against the proband’s genomic data. This code is significant nationally because rapid genomic comparator testing can accelerate diagnosis for critically ill patients, influence clinical decision-making, and intersect with evolving coverage policies for advanced molecular diagnostics. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what this code represents, payer coverage considerations, and the clinical context in which the service is used. The publication summarizes common billing modifiers associated with similar services, typical site-of-service settings, and practical coding notes tied to the PLA designation. It also outlines the implications of PLA coding — namely that the code is proprietary to a single manufacturer or laboratory — and highlights how that affects claim recognition and policy language. Data not available in the input is identified where applicable, and the content focuses on national relevance rather than state-specific policy.
Billing Code Overview
CPT code 0583U is a Proprietary Laboratory Analyses (PLA) code for the Rapid Genome Sequencing Family Member Comparator offered by Mayo Clinic. The test uses rapid whole genome sequencing of a family member to compare genomic results with the proband (the primary patient) to aid in diagnostic interpretation.
Service type: Genomic diagnostic testing using rapid whole genome sequencing for family-member comparator analysis
Typical site of service: Clinical molecular diagnostics laboratory or specialized genomic testing center; results support inpatient or outpatient clinical care as needed
Clinical & Coding Specifications
Clinical Context
A newborn in the neonatal intensive care unit (NICU) presents with unexplained, rapidly progressive multisystem abnormalities including refractory seizures, hypotonia, metabolic instability, and organ dysfunction. Initial metabolic and infectious workups are inconclusive. The neonatology team, genetics consult service, and clinical laboratory coordinate expedited genomic testing. A rapid whole genome sequencing (rWGS) is performed on the proband to identify a likely pathogenic variant, and family member comparator testing is ordered to sequence a parent or sibling to aid interpretation of variants of uncertain significance and determine inheritance (de novo vs inherited). The comparator sample is collected from a blood draw or buccal swab from the chosen family member, sent to the Mayo Clinic laboratory under urgent transport with clear labeling for the 0583U Rapid Genome Sequencing Family Member Comparator. Results are integrated into the clinical genetics report to support diagnostic classification, immediate management decisions (e.g., targeted therapies, medication avoidance), and genetic counseling for the family. Typical site of service is the hospital inpatient setting (NICU or pediatric ward) or an affiliated outpatient genetics clinic when rapid sequencing is indicated but the patient is not currently hospitalized. Service type: Proprietary Laboratory Analyses (PLA) — laboratory diagnostic genomic testing performed by Mayo Clinic specific assay 0583U.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|